Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...